Quality of life measures(measured on the EQ‐5D; higher = better) (at 12 months) · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Contrast sensitivity at Level E [18 cycles/degree] at 12 months Higher scores represent better contrast sensitivity. · people with non‐exudative AMD (AREDS 2 to 4)
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Simulator task ratings (range 0–100; higher score indicates better performance) · ophthalmology trainees for cataract surgery
1 finding from 1 review
Supervising physician ratingsin simulated settings (range 0–100; higher score indicates better performance) · ophthalmology trainees for cataract surgery
1 finding from 1 review
Contrast sensitivity (log contrast threshold) Measured using a Pelli‐Robson chart. Higher scores represent better contrast sensitivity. · people with neovascular AMD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Contrast sensitivity (log contrast threshold) Measured using a Pelli‐Robson chart. Higher scores represent better contrast sensitivity. · people with neovascular AMD
1 finding from 1 review
no estimate extracted
Studies not reported
Low
QoL · people with BRVO
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · people with BRVO
1 finding from 1 review
QoL · macular oedema secondary to branch retinal vein occlusion
1 finding from 1 review
Change in BCVA at 1 year (ETDRS letters score, the higher the score the better) · people with neovascular age‐related macular degeneration
1 finding from 1 review
QoL · people with neovascular age‐related macular degeneration
1 finding from 1 review
Change in BCVA at 1 year (ETDRS letters score, the higher the score the better) · people with neovascular age‐related macular degeneration
1 finding from 1 review
Mean higher‐order aberrations (HOAs) post‐treatment, measured by machine with wavefront sensor ‐ 12 months · Adults with refractive errors
1 finding from 1 review
Mean higher‐order aberrations (HOAs) post‐treatment, measured by machine with wavefront sensor ‐ 12 months · Adults with refractive errors
1 finding from 1 review
Proportion of eyes that had lost 1 or more lines of best spectacle‐corrected visual acuity (BSCVA) posttreatment‐procedure LASIK; Mean higher‐order aberrations (HOAs) post‐treatment, measured by machine with wavefront sensor; proportion of eyes wi... · Adults with refractive errors
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Visual acuity · people with simple rhegmatogenous retinal detachments
1 finding from 1 review
Tear film stability · people with dry eyea
Combined oral omega‐3 and omega‐6 PUFAs showed no clear difference in change in tear film stability, measured using tear break‐up time… compared with placebo (moderate certainty).
1 finding from 1 review
Aqueous tear production · people with dry eyea
Oral long‐chain omega‐3 PUFAs showed no clear difference in change in Schirmer test (aqueous tear production, measured in mm/5… compared with oral omega‐6 PUFAs (low certainty).
1 finding from 1 review
Tear film stability · people with dry eyea
1 finding from 1 review
Aqueous tear production · people with dry eyea
Oral long‐chain omega‐3 PUFAs (ie, EPA and DHA) showed no clear difference in change in Schirmer test (aqueous tear production, measured in mm/5… compared with placebo or no treatment (moderate certainty).
1 finding from 1 review